Cargando…
Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson’s disease
The ability to use blood to predict the outcomes of Parkinson’s disease, including disease progression and cognitive and motor complications, would be of significant clinical value. We undertook bulk RNA sequencing from the caudate and putamen of postmortem Parkinson’s disease (n = 35) and control (...
Autores principales: | Irmady, Krithi, Hale, Caryn R., Qadri, Rizwana, Fak, John, Simelane, Sitsandziwe, Carroll, Thomas, Przedborski, Serge, Darnell, Robert B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322907/ https://www.ncbi.nlm.nih.gov/pubmed/37407548 http://dx.doi.org/10.1038/s41467-023-39652-6 |
Ejemplares similares
-
Arm Posturing in a Patient Following Stroke: Dystonia, Levitation, Synkinesis, or Spasticity?
por: Irmady, Krithi, et al.
Publicado: (2015) -
Neuroprotection and neuroregeneration triggered through the FUS-induced opening of the blood-brain barrier in a Parkinson’s mouse model
por: Konofagou, Elisa, et al.
Publicado: (2015) -
FMRP regulates mRNAs encoding distinct functions in the cell body and dendrites of CA1 pyramidal neurons
por: Hale, Caryn R, et al.
Publicado: (2021) -
Parkinson’s disease: animal models and dopaminergic cell vulnerability
por: Blesa, Javier, et al.
Publicado: (2014) -
FMRP has a cell-type-specific role in CA1 pyramidal neurons to regulate autism-related transcripts and circadian memory
por: Sawicka, Kirsty, et al.
Publicado: (2019)